Figure S3 from Novel Thienoduocarmycin–Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies

crossref(2023)

引用 0|浏览4
暂无评分
摘要

Biochemical characterization of trastuzumab conjugated to MMAE and Deruxtecan

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要